These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39117022)

  • 1. TFEB activator tanshinone IIA and derivatives derived from Salvia miltiorrhiza Bge. Attenuate hepatic steatosis and insulin resistance.
    Zheng L; Li B; Yuan A; Bi S; Puscher H; Liu C; Qiao L; Qiao Y; Wang S; Zhang Y
    J Ethnopharmacol; 2024 Dec; 335():118662. PubMed ID: 39117022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
    Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
    Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Probiotics and
    Wang W; Xu AL; Li ZC; Li Y; Xu SF; Sang HC; Zhi F
    Diabetes Metab J; 2020 Apr; 44(2):336-348. PubMed ID: 31950772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
    Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
    J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
    Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
    Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease.
    Zhang H; Lu J; Liu H; Guan L; Xu S; Wang Z; Qiu Y; Liu H; Peng L; Men X
    Pharmacol Res; 2021 Dec; 174():105964. PubMed ID: 34732369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrus aurantium L. var. amara Engl. inhibited lipid accumulation in 3T3-L1 cells and Caenorhabditis elegans and prevented obesity in high-fat diet-fed mice.
    Shen CY; Wan L; Wang TX; Jiang JG
    Pharmacol Res; 2019 Sep; 147():104347. PubMed ID: 31315066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate improves hepatic steatosis, insulin resistance, and shapes the gut microbiome via TFEB-autophagy in NAFLD mice.
    Zhang D; Ma Y; Liu J; Wang D; Geng Z; Wen D; Chen H; Wang H; Li L; Zhu X; Wang X; Huang M; Zou C; Chen Y; Ma L
    Eur J Pharmacol; 2023 Dec; 960():176159. PubMed ID: 37898287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
    J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modulation of Luffa cylindrica (L.) Roem supplementation on gene expression and amino acid profiles in liver for alleviating hepatic steatosis via gut microbiota in high-fat diet-fed mice: insight from hepatic transcriptome analysis.
    Zhang L; Wang P; Shi M; Fang Z; Ji J; Liao X; Hu X; Chen F
    J Nutr Biochem; 2020 Jun; 80():108365. PubMed ID: 32217466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrocurcumin ameliorates hepatic steatosis by restoring hepatocytes lipophagy through mTORC1-TFEB pathway in nonalcoholic steatohepatitis.
    Wu J; Guan F; Huang H; Chen H; Liu Y; Zhang S; Li M; Chen J
    Biomed Pharmacother; 2024 Sep; 178():117297. PubMed ID: 39137653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.
    Lee JE; Lee SM; Jung J
    Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Ai ZL; Zhang X; Ge W; Zhong YB; Wang HY; Zuo ZY; Liu DY
    World J Gastroenterol; 2022 Nov; 28(43):6131-6156. PubMed ID: 36483153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-NAFLD effect of defatted walnut powder extract in high fat diet-induced C57BL/6 mice by modulating the gut microbiota.
    Ren SM; Zhang QZ; Chen ML; Jiang M; Zhou Y; Xu XJ; Wang DM; Pan YN; Liu XQ
    J Ethnopharmacol; 2021 Apr; 270():113814. PubMed ID: 33444725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatics and multiomics reveal Liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota.
    Yang S; Wei Z; Luo J; Wang X; Chen G; Guan X; She Z; Liu W; Tong Y; Liu H; Wen M; Chen H; Zhu P; Li G; Wang D; Huang L; Xu S; Chen D; Zhang Q; Wei Y
    Phytomedicine; 2024 Sep; 132():155834. PubMed ID: 38941818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tangerine Peel-Derived Exosome-Like Nanovesicles Alleviate Hepatic Steatosis Induced by Type 2 Diabetes: Evidenced by Regulating Lipid Metabolism and Intestinal Microflora.
    Zou J; Song Q; Shaw PC; Wu Y; Zuo Z; Yu R
    Int J Nanomedicine; 2024; 19():10023-10043. PubMed ID: 39371479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Black rice anthocyanins alleviate hyperlipidemia, liver steatosis and insulin resistance by regulating lipid metabolism and gut microbiota in obese mice.
    Song H; Shen X; Zhou Y; Zheng X
    Food Funct; 2021 Oct; 12(20):10160-10170. PubMed ID: 34528983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.